vs

Side-by-side financial comparison of SPAR Group, Inc. (SGRP) and TriSalus Life Sciences, Inc. (TLSI). Click either name above to swap in a different company.

SPAR Group, Inc. is the larger business by last-quarter revenue ($22.0M vs $13.2M, roughly 1.7× TriSalus Life Sciences, Inc.). TriSalus Life Sciences, Inc. runs the higher net margin — -73.9% vs -74.1%, a 0.3% gap on every dollar of revenue. On growth, TriSalus Life Sciences, Inc. posted the faster year-over-year revenue change (59.8% vs -33.4%). TriSalus Life Sciences, Inc. produced more free cash flow last quarter ($-2.5M vs $-3.9M). Over the past eight quarters, TriSalus Life Sciences, Inc.'s revenue compounded faster (43.0% CAGR vs -33.2%).

SPAR, originally "DESPAR", styled as "DE SPAR", is a Dutch multinational franchise that provides branding, supplies and support services for independently owned and operated food retail stores. It was founded in the Netherlands in 1932, by Adriaan van Well, although the largest number of stores are located in the United Kingdom.

TriSalus Life Sciences, Inc. is a clinical-stage biotechnology company focused on advancing immuno-oncology and interventional oncology solutions. It develops proprietary targeted drug delivery technologies designed to improve treatment efficacy for patients with liver, pancreatic and other hard-to-treat solid tumors, primarily operating in North American markets via partnerships with clinical care and research institutions.

SGRP vs TLSI — Head-to-Head

Bigger by revenue
SGRP
SGRP
1.7× larger
SGRP
$22.0M
$13.2M
TLSI
Growing faster (revenue YoY)
TLSI
TLSI
+93.2% gap
TLSI
59.8%
-33.4%
SGRP
Higher net margin
TLSI
TLSI
0.3% more per $
TLSI
-73.9%
-74.1%
SGRP
More free cash flow
TLSI
TLSI
$1.4M more FCF
TLSI
$-2.5M
$-3.9M
SGRP
Faster 2-yr revenue CAGR
TLSI
TLSI
Annualised
TLSI
43.0%
-33.2%
SGRP

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
SGRP
SGRP
TLSI
TLSI
Revenue
$22.0M
$13.2M
Net Profit
$-16.3M
$-9.8M
Gross Margin
-10.6%
86.7%
Operating Margin
-57.8%
-24.8%
Net Margin
-74.1%
-73.9%
Revenue YoY
-33.4%
59.8%
Net Profit YoY
-186.2%
3.5%
EPS (diluted)
$-0.69
$-0.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
SGRP
SGRP
TLSI
TLSI
Q4 25
$22.0M
$13.2M
Q3 25
$41.4M
$11.6M
Q2 25
$38.6M
$11.2M
Q1 25
$34.0M
$9.2M
Q4 24
$33.0M
$8.3M
Q3 24
$37.8M
$7.3M
Q2 24
$43.4M
$7.4M
Q1 24
$49.4M
$6.5M
Net Profit
SGRP
SGRP
TLSI
TLSI
Q4 25
$-16.3M
$-9.8M
Q3 25
$-8.8M
$-10.8M
Q2 25
$-1.0K
$-8.3M
Q1 25
$462.0K
$-10.4M
Q4 24
$-5.7M
$-10.1M
Q3 24
$-182.0K
$-2.4M
Q2 24
$-3.9M
$-4.3M
Q1 24
$6.6M
$-13.2M
Gross Margin
SGRP
SGRP
TLSI
TLSI
Q4 25
-10.6%
86.7%
Q3 25
18.6%
83.5%
Q2 25
23.5%
83.9%
Q1 25
21.4%
83.7%
Q4 24
19.6%
85.3%
Q3 24
22.3%
86.3%
Q2 24
20.7%
87.6%
Q1 24
19.7%
85.0%
Operating Margin
SGRP
SGRP
TLSI
TLSI
Q4 25
-57.8%
-24.8%
Q3 25
-14.3%
-77.9%
Q2 25
1.9%
-65.4%
Q1 25
3.0%
-79.9%
Q4 24
-16.6%
-91.8%
Q3 24
-4.0%
-118.9%
Q2 24
-2.2%
-111.0%
Q1 24
17.6%
-180.8%
Net Margin
SGRP
SGRP
TLSI
TLSI
Q4 25
-74.1%
-73.9%
Q3 25
-21.2%
-93.5%
Q2 25
-0.0%
-73.9%
Q1 25
1.4%
-113.2%
Q4 24
-17.3%
-122.4%
Q3 24
-0.5%
-32.6%
Q2 24
-9.0%
-58.8%
Q1 24
13.4%
-204.5%
EPS (diluted)
SGRP
SGRP
TLSI
TLSI
Q4 25
$-0.69
$-0.22
Q3 25
$-0.37
$-0.96
Q2 25
$0.00
$-0.27
Q1 25
$0.02
$-0.39
Q4 24
$-0.24
$-0.38
Q3 24
$-0.01
$-0.12
Q2 24
$-0.16
$-0.21
Q1 24
$0.28
$-0.60

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
SGRP
SGRP
TLSI
TLSI
Cash + ST InvestmentsLiquidity on hand
$3.3M
$20.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$622.0K
$-33.9M
Total Assets
$44.1M
$35.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
SGRP
SGRP
TLSI
TLSI
Q4 25
$3.3M
$20.4M
Q3 25
$8.2M
$22.7M
Q2 25
$13.9M
$26.5M
Q1 25
$17.9M
$13.0M
Q4 24
$18.2M
$8.5M
Q3 24
$19.7M
$11.3M
Q2 24
$21.7M
$16.5M
Q1 24
$16.6M
$4.0M
Stockholders' Equity
SGRP
SGRP
TLSI
TLSI
Q4 25
$622.0K
$-33.9M
Q3 25
$16.6M
$-26.7M
Q2 25
$24.9M
$-19.4M
Q1 25
$24.7M
$-34.4M
Q4 24
$24.3M
$-25.9M
Q3 24
$29.3M
$-20.4M
Q2 24
$29.4M
$-25.3M
Q1 24
$33.0M
$-36.0M
Total Assets
SGRP
SGRP
TLSI
TLSI
Q4 25
$44.1M
$35.3M
Q3 25
$61.7M
$36.5M
Q2 25
$71.6M
$41.3M
Q1 25
$70.2M
$28.6M
Q4 24
$56.4M
$24.0M
Q3 24
$67.4M
$27.5M
Q2 24
$70.0M
$32.4M
Q1 24
$104.5M
$17.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
SGRP
SGRP
TLSI
TLSI
Operating Cash FlowLast quarter
$-2.5M
$-2.5M
Free Cash FlowOCF − Capex
$-3.9M
$-2.5M
FCF MarginFCF / Revenue
-17.8%
-19.1%
Capex IntensityCapex / Revenue
6.6%
0.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-21.4M
$-19.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
SGRP
SGRP
TLSI
TLSI
Q4 25
$-2.5M
$-2.5M
Q3 25
$-4.1M
$-3.7M
Q2 25
$-7.9M
$-7.3M
Q1 25
$-4.0M
$-4.5M
Q4 24
$65.0K
$-5.7M
Q3 24
$-900.0K
$-10.8M
Q2 24
$-445.0K
$-13.4M
Q1 24
$615.0K
$-10.9M
Free Cash Flow
SGRP
SGRP
TLSI
TLSI
Q4 25
$-3.9M
$-2.5M
Q3 25
$-4.6M
$-3.9M
Q2 25
$-8.3M
$-7.4M
Q1 25
$-4.6M
$-5.3M
Q4 24
$-166.0K
$-5.8M
Q3 24
$-1.0M
$-11.0M
Q2 24
$-785.0K
$-13.5M
Q1 24
$184.0K
$-10.9M
FCF Margin
SGRP
SGRP
TLSI
TLSI
Q4 25
-17.8%
-19.1%
Q3 25
-11.2%
-33.9%
Q2 25
-21.5%
-66.1%
Q1 25
-13.4%
-57.3%
Q4 24
-0.5%
-69.7%
Q3 24
-2.7%
-149.9%
Q2 24
-1.8%
-183.1%
Q1 24
0.4%
-169.3%
Capex Intensity
SGRP
SGRP
TLSI
TLSI
Q4 25
6.6%
0.3%
Q3 25
1.4%
1.9%
Q2 25
1.1%
0.8%
Q1 25
1.5%
8.2%
Q4 24
0.7%
0.6%
Q3 24
0.3%
2.3%
Q2 24
0.8%
0.8%
Q1 24
0.9%
1.0%
Cash Conversion
SGRP
SGRP
TLSI
TLSI
Q4 25
Q3 25
Q2 25
Q1 25
-8.75×
Q4 24
Q3 24
Q2 24
Q1 24
0.09×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons